1. Kissinger PJ, Gaydos CA, Seña AC, et al. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention
Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis. 2022; 13;74(Suppl_2):S152-S161.
2. Harp DF, Chowdhury I. Trichomoniasis: evaluation to execution. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):3-9.
3. Beri D, Yadav P, Devi HRN, Narayana C, Gadara D, Tatu U. Demonstration and Characterization of Cyst-Like Structures in the Life Cycle of Trichomonas vaginalis. Front Cell Infect Microbiol.
2020; 14;9:430.
4. Dias-Lopes G, Saboia-Vahia L, Margotti ET, et al. Morphologic study of the effect of iron on pseudocyst formation in Trichomonas vaginalis and its interaction with human epithelial cells.
Mem Inst Oswaldo Cruz. 2017; 112;10: 664-673.
5. Özcel MA, Zeyrek FY. Trichomoniasis. Özcel’in Tıbbi Parazit Hastalıkları. Özcel MA, Özbel Y, Ak M, editörler. Özcel’in Tıbbi Parazit Hastalıkları. İzmir: Meta Basım; 2007, 431-437.
6. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm) (Erişim tarihi 13.12.2023).
7. Kissinger P. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect Dis. 2015; 5;15:307.
8. Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev. 1998;11(2):300–17.
9. Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol. 2017;168(9-10):782-792.
10. (https://www.who.int/en/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis). Erişim tarihi: 14.12.2023)
11. Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;
1;97(8):548-562P.
12. Mabaso N, Abbai NS. A review on Trichomonas vaginalis infections in women from Africa. S Afr J Infect Dis. 2021; 10;36(1):254.
13. Beyhan YE. A systematic review of Trichomonas vaginalis in Turkey from 2002 to 2020. Acta Trop. 2021; 221:105995.
14. Ertabaklar H, Caner A, Döşkaya M, Demirtaş LO, Töz SO, Ertuğ S, Gürüz Y. Comparison of polymerase chain reaction with wet mount and culture methods for the diagnosis of trichomoni-
asis. Turkiye Parazitol Derg. 2011; 35(1):1-5.
15. Kusdian G, Woehle C, Martin WF, Gould SB. The actin-based machinery of Trichomonas vaginalis mediates flagellate-amoeboid transition and migration across host tissue. Cell Microbiol.
2013;15(10):1707-21.
16. Malla N. Human Trichomoniasis due to Trichomonas vaginalis – Current Perspectives. Sexually Transmitted Infections 2012, 107-123.
17. Ibanez-Escribano A, Nogal-Ruiz JJ, Aran VJ, et al. Determination of internal transcribed spacer regions (ITS) in Trichomonas vaginalis isolates and differentiation among Trichomonas spe-
cies. Parasitol Int 2014; 63: 427-31.
18. Ertabaklar H, Ertuğ S, Çalışkan SÖ, Malatyalı E, Bozdoğan B. Use of Internal Transcribed Spacer Sequence Polymorphisms as a Method for Trichomonas vaginalis Genotyping. Turkiye
Parazitol Derg. 2018;42(1):6-10.
19. Malatyali E, Guclu O, Yildiz I, Bozdogan B, Ertug S, Ertabaklar H. Molecular characterisation of Trichomonas vaginalis isolates in Southwest Turkey with multilocus sequence typing and
genetic structure analysis in relation to different countries. Infect Genet Evol. 2020;84:104459.
20. Hawksworth J, Levy M, Smale C, et al. Population structure and genetic diversity of the parasite Trichomonas vaginalis in Bristol, UK. Infect Genet Evol. 2015; 34:36-43.
21. Demirağ S, Malatyalı E, Ertuğ S, Ertabaklar H. Determination of Trichomonas vaginalis Genotypes Using PCR-Restriction Fragment Length Polymorphism (RFLP). Turkiye Parazitol Derg.
2017; 41(4):188-191.
22. Crucitti T, Abdellati S, Van Dyck E, Buvé A. Molecular typing of the actin gene of Trichomonas vaginalis isolates by PCR-restriction fragment length polymorphism. Clin Microbiol Infect.
2008;14(9):844-52.
23. Lesiak-Markowicz I, Walochnik J, Stary A, Fürnkranz U. Characterisation of Trichomonas vaginalis Isolates Collected from Patients in Vienna between 2019 and 2021. Int J Mol Sci.
2022,17;23(20):12422.
24. Graves KJ, Ghosh AP, Schmidt N, et al. Trichomonas vaginalis virus among women with trichomoniasis and association with demographics, clinical outcomes, and metronidazole resistan-
ce. Clin. Infect. Dis. 2019; 69: 2170–2176.
25. Ertabaklar H, Malatyali E, Özün Özbay EP, et al. Microsatellite-Based Genotyping, Analysis of Population Structure, Presence of Trichomonas vaginalis Virus (TVV) and Mycoplasma homi-
nis in T. vaginalis Isolates from Southwest of Turkey. Iran J Parasitol. 2021 Jan-Mar;16(1):81-90.
26. Karaman Ü, Atambay M, Aycan ÖM, Daldal N. Trichomonas vaginalis’in çeşitli ortamlarda ve farklı ısılarda yaşam süresi. Türkiye Parazitoloji Dergisi 2004, 28(1), 18-20.
27. Wolner-Hanssen P, Krieger JN, Stevens CE, et al. Clinical manifestations of vaginal trichomoniasis. JAMA. 1989;261(4):571–6.
28. Daskalakis, G.; Psarris, A.; Koutras, A. et al. Maternal Infection and Preterm Birth: From Molecular Basis to Clinical Implications. Children 2023, 10, 907.
29. Sena AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2007;44(1):13–22.
30. Menezes CB, Frasson AP, Tasca T. Trichomoniasis – are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide? Microbial Cell 2016, 3(9),
404 – 419.
31. Masha SC, Cools P, Sanders EJ, Vaneechoutte M, Crucitti T. Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis. Sex Transm Infect. 2019; 95(1):36-42.
32. Mei X, Zhang R, Li D, et al. Association between the infections of Trichomonas vaginalis and uterine cervical human papillomavirus: A meta-analysis. J. Obstet. Gynaecol. J. Inst. Obstet.
Gynaecol. 2023, 43, 2194986.
33. Fazlollahpour-Naghibi A, Bagheri K, Almukhtar M, et al. Trichomonas vaginalis infection and risk of cervical neoplasia: A systematic review and meta-analysis. PLoS ONE 2023; 18, e0288443
34. Meites E, Gaydos CA, Hobbs MM, et al. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections Trichomoniasis and T. vagi-
nalis. Clinical Infectious Diseaes 2015, 15(61), 837-48.
35. Khatoon R, Jahan N, Khan HM, Rabbani T, Ahmad S. Evaluation of different staining techniques in the diagnosis of Trichomonas vaginalis infection in females of reproductive age group.
Journal of Clinical and Diagnostic Research 2014, 8(12), DC05–DC08.
36. Hobbs MM, Sena AC. Modern diagnosis of Trichomonas vaginalis infection. Sexuel Transmitted Infections 2013, 89(6), 434-438.
37. Alderete JF, Chan H. Point-of-Care Diagnostic for Trichomonas vaginalis, the Most Prevalent, Non-Viral Sexually Transmitted Infection. Pathogens. 2023; 3;12(1):77.
38. Graves KJ, Novak J, Secor WE, Kissinger PJ, Schwebke JR, Muzny CA. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Trichomonas vaginalis. Parasito-
logy. 2020;147(13):1383-1391.
39. Ertabaklar H, Yaman Karadam S, Malatyalı E, Ertuğ S. Trichomonas vaginalis klinik izolatlarında in vitro metronidazol direncinin araştırılması [Investigation of in vitro metronidazole resis-
tance in the clinical isolates of Trichomonas vaginalis]. Mikrobiyol Bul. 2016;50(4):552-558.
40. Matthew MA, Yang N, Ketzis J, ve ark. Trichomonas tenax: A Neglected Protozoan Infection in the Oral Cavities of Humans and Dogs-A Scoping Review. Trop Med Infect Dis. 2023 Jan
12;8(1):60.
41. Abualqomsaan M, Töz SO, Yolasiğmaz A, ve ark. Periodontal Hastaliği Bulunan Kişilerde Diş Eti Plaklarinda Entamoeba gingivalis ve Trichomonas tenax Araştirilmasi Turkiye Parazitol Derg.
2010;34(2):91-4.
42. Abdo SM, Ghallab MMI, Elhawary NM, Elhadad H. Pentatrichomonas hominis and other intestinal parasites in school-aged children: coproscopic survey. J Parasit Dis. 2022;46(3):896-900.